{
  "risk_score_0_to_1": 0.08,
  "confidence_0_to_1": 0.88,
  "dominant_mechanisms": [
    {"mechanism": "mitochondrial_dysfunction", "score_0_to_1": 0.05},
    {"mechanism": "reactive_metabolite_formation", "score_0_to_1": 0.15},
    {"mechanism": "cholestasis_bsep_inhibition", "score_0_to_1": 0.05},
    {"mechanism": "immune_mediated_injury", "score_0_to_1": 0.10},
    {"mechanism": "oxidative_stress", "score_0_to_1": 0.10}
  ],
  "time_to_onset": "unknown",
  "dose_dependence": "minimal_dose_relationship",
  "reversibility": "reversible_if_early",
  "uncertainties": [
    "Limited hepatotoxicity surveillance data for meperidine/pethidine in modern clinical practice",
    "Normeperidine accumulation in renal impairment causes neurotoxicity but hepatotoxic potential unclear",
    "Historical case reports may involve confounding from polysubstance use or underlying liver disease",
    "Relative hepatotoxicity compared to other opioids difficult to assess due to decreased contemporary use"
  ],
  "citations": [
    "Latta KS, et al. Meperidine: a critical review. Am J Ther. 2002;9(1):53-68.",
    "citation unavailable",
    "citation unavailable"
  ]
}